Intracellular adhesion molecule-1 (ICAM-1), a cellular adhesion molecule that mediates the interaction of activated endothelial cells with leukocytes, is involved in various inflammatory and cardiovascular disorders. The relation between these markers and genetic polymorphism, however, remains to be elucidated. The aim of this study is to estimate the effect of a single-base polymorphism at codon 241 in exon 4 of ICAM-1 gene on serum sICAM-1 concentration in a healthy population, taking into account other biological determinants of sICAM-1 level. Serum sICAM-1 levels and the G/R241 polymorphism of the ICAM-1 gene were measured in a large healthy population consisting of 413 children aged 6-21 years and 363 adults aged 38-55 years extracted from the Stanislas cohort. The R241 allele was significantly associated with lower sICAM-1 levels and explained 3.4 and 1.9% of the sICAM-1 variability in children and adults, respectively. A codominant pattern contributed better to the model after adjustment for covariates as the RR homozygote effect was higher than that of the GR heterozygote. Moreover, significant independent associations were found between sICAM-1 and smoking, insulin resistance index (HOMA IR), interleukin-6 level, and alkaline phosphatase and aspartate aminotransferase activities. In conclusion, this study revealed a significant association between the G/R241 ICAM-1 polymorphism and serum sICAM-1 levels, probably due to the impairment in binding of ICAM-1 to leukocyte integrin Mac-1 protein.
Introduction
The intercellular adhesion molecule-1 (ICAM-1) is expressed on vascular endothelium and plays a key role in the trans-endothelial migration of leukocytes.
1 ICAM-1 is a cell-surface glycoprotein that belongs to the immunoglobulin superfamily and functions as a ligand for b2 integrin molecules (LFA-1 and Mac-1) present on leukocytes. 1 The circulating soluble ICAM-1 (sICAM-1) molecule results from a proteolytic cleavage of the membrane-bound protein and thus reflects ICAM-1 expression on endothelium. 2 sICAM-1 can be measured in the serum of healthy subjects 3 and its level is increased in numerous diseases such as inflammatory and auto-immune disorders, 4 infections, 5 graft rejections, 6 cancer 7 and cardiovascular diseases. 8 The human ICAM-1 gene is located on chromosome 19p13.3 -p13.2, and a single-base polymorphism in codon 241 with amino-acid substitution has been described. 9 This polymorphic site G/R241 in exon 4 (also known as G/R214 if the signal peptide is not included in the codon numbering) occurs in the third immunoglobulin domain 9, 10 and has been shown to be of importance in binding to leukocyte integrin Mac-1. 10 However, the exact functional relevance of this mutation remains incompletely understood. The G/R241 polymorphism has been shown to be associated with ulcerative colitis, 11 Crohn's disease, 12 rheumatoid arthritis, 13 polymyalgia rheumatica/giant cell arteritis 14 and Behc¸et's disease. 15 However, other studies failed to find a significant contribution in inflammatory diseases 16 -24 or atherosclerosis. 25 Despite the fact that all the concerned diseases are characterized by higher levels of inflammatory markers including sICAM-1, 4, 8, 26 there is still no study of the association between this mutation and the protein level in serum.
The aim of the present study is to estimate the association between the G/R241 polymorphism and serum sICAM-1 levels in a healthy population, taking into account the other biological determinants. In addition, potential interactions between the G/R241 polymorphism and age, sex and smoking status were tested.
Methods and materials

Subjects
The sample population included 182 families with various patterns including one or two parents and at least one child. The subjects -212 boys and 201 girls aged 6 -21 years, and 182 men and 181 women aged 38 -55 yearswere drawn from the Stanislas cohort, a longitudinal family study recruited in 1994 -1995, 27 where participants were of French origin and came from the Vosges and the south of Meurthe et Moselle (eastern region of France). Each subject gave a written informed consent to participate in the study, approved by the Local Ethics Committee of Nancy, France. This population came back for a second visit in 1999 -2000. For this specific study, the subjects were selected with the following criteria: to be present at the first (1994 -1995) 
Genotyping
Genomic DNA was extracted by the salting-out method. 28 ICAM-1 genotyping was performed using a prototypic multilocus genotyping assay focused on cardiovascular diseases essentially as in Cheng et al. 29 Briefly, each sample is amplified by a 33 cycle 5 polymerase chain reaction (25 ng of genomic DNA). One of the biotinylated primer pairs in the Multiplex was designed to amplify the gene of ICAM-1. PCR product was then hybridized to oligonucleotide probes that have been immobilized in a linear array on a backed nylon membrane strip. The colorimetric detection is based on streptavidin -horseradish peroxidase conjugate and substrates.
Statistical analysis
Statistical analyses were performed with the SAS software version 8.01 (SAS Institute Inc., USA). As the distribution of serum concentrations of triglycerides, CRP, Il-6, TNF-a and sICAM-1, activities of AST and ALP and HOMA index were skewed, log 10 -transformations of these values were applied for setting purpose. Agreement of the genotype frequencies with the Hardy -Weinberg equilibrium was tested by using a w 2 goodness-of-fit test.
ANOVA and pairwise comparison procedure with Bonferroni correction were performed to test differences in the sICAM-1 level between age and sex groups.
Stepwise multiple regression analysis was used to test relations between sICAM-1 level and ICAM-1 gene polymorphism accounting for age, sex and the other potential covariates listed in Table 1 . Analysis was carried out separately in children (6 -21 years) and adults (38 -55 years). ICAM-1 R241 genotype was tested in autosomal dominant (GG vs GR þ RR), codominant (GG vs GR vs RR), recessive (GG þ GR vs RR) and allelic dose effect models. In addition, interaction terms between ICAM-1 polymorphism (as dominant score: GG vs GR þ RR) and age (as For both children and adult groups, the best model for age-and sex-adjusted sICAM-1 level was summarized by multiple linear regression with ICAM-1 polymorphism and the covariates significantly associated at least in one group. As individuals within a family were not independent, ANOVA and final multiple linear regression analysis were conducted by using the SAS GENMOD procedure with a family factor as repeated statement. GENMOD was based on the generalized estimating equation (GEE). GEE provides a practical method with reasonable statistical efficiency to analyze correlated data such as familial data by modelling the covariance structure of the correlated measurements. Unlike other methods, the measurements must not be assumed to be multivariate normal. 30 
Results
Baseline characteristics
Baseline characteristics of the population are given in Table 1 . The means7SD for age were 15.473.3, 15.473.0, 44.773.9 and 43.174.1 years for boys, girls, men and women, respectively. Mean values or frequencies for BMI, blood pressure, alcohol, tobacco and drug intake, and all biological constituents (leukocyte and platelet count, triglycerides, total cholesterol, apoA-I, apoB, glucose, insulin, HOMA index, CRP, Il-6, TNF-a, AST, ALP) were in accordance with the values found in apparently healthy individuals of the same age and sex. Mean levels of sICAM-1 were significantly different between the four groups (Pr0.001).
Allelic frequencies of the ICAM-1 polymorphism were in Hardy -Weinberg equilibrium in children and adults. The R241 allelic frequencies were 9.7, 10.9, 10.2 and 11.9% for boys, girls, men and women, respectively.
Effects of age and sex on sICAM-1 level Figure 1 shows geometric means for serum sICAM-1 level according to sex and age (6 -11, 12 -14, 15 -17 and 18 -21 years for children; 38 -42, 43 -47 and 48 -55 years for adults). From 6 to 21 years, sICAM-1 levels significantly decreased for both boys and girls (global ANOVA, Pp0.001) and the levels did not differ between the sexes. According to the multiple comparison test, sICAM-1 concentrations did not significantly differ between 15 and 21 years for both boys and girls, and the average level for the three age groups (6 -11, 12 -14 and 15 -21 years) significantly differed from each other. For adults of both sexes, there was no significant difference due to the age between 38 and 55 years, while sICAM-1 levels were lower in women than in men (global ANOVA, Pp0.01), probably due to discrepancy in the older age group (48 -55 years). However, the multiple comparison test showed that sICAM-1 levels did not significantly differ between sexes within each age group (38 -42, 43 -47 and 48 -55 years).
Determinants of serum sICAM-1 level
In multiple regression analysis (Table 2) , ICAM-1 R241 polymorphism was associated with sICAM-1 levels after adjustment for age, sex, smoking status, Il-6, AST, ALP and HOMA index. Among the four tested patterns (dominant (GG vs GR þ RR), codominant (GG vs GR vs RR), recessive (GG þ GR vs RR) and allelic (R vs G)), the codominant pattern contributed better to the model after adjustment for covariates improvement (in children R 2 values were 0.034 vs 0.027, 0.012 and 0.031; in adults 0.019 vs 0.012, 0.011 and 0.016 for codominant, dominant, recessive and allelic patterns, respectively). GR and RR genotypes were associated with lower sICAM-1 levels in both children and adults groups, the GG genotype being the reference group. As expected, the RR homozygote effect was higher than that of the GR heterozygote. Although genotype contribution was higher in children than in adults, the interaction term (product: codominant pattern * age group) was not significant in regression analysis using the overall population.
Covariates and polymorphism explained 20.1 and 26.4% of the variability of sICAM-1 in children and adults, respectively. In these two groups, Il-6 level, AST and ALP activities were positively related to sICAM-1 level. For children only, the HOMA index was positively correlated with sICAM-1 concentration, and for adults only, the sICAM-1 level was higher among heavy smokers. Tests for interactions between polymorphism and age, sex or smoking status were not significant (data not shown).
Discussion
The present study is the first evidence for an association between G/R241 ICAM-1 gene polymorphism and serum 
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A Ponthieux et al sICAM-1 concentration. We found that the R241 allele was associated with lower sICAM-1 level independently of other factors influencing sICAM-1 concentration (smoking status, HOMA index, Il-6 concentration, and AST and ALP activities) in a codominant genetic model. To date, only in one study the relation between the G/R241 mutation and sICAM-1 level in a healthy sample of 44 Palestinians and Jordanians was investigated, but the authors 23 failed to find a significant association probably due to lack of power and very low R241 allelic frequency (about 1.5%). sICAM-1 mean concentrations and variability observed in the present study are similar to those reported in other healthy populations (using the commercial ELISA kit from R&D System). 31 -36 Regarding G/R241 ICAM-1 polymorphism, there is a heterogeneity in the genotype distribution in healthy populations across the world with ethnic differences in R241 allele frequency. 20 In particular, across Europe, R241 allele frequency was higher in the north compared with the south: 18% in Poland; 17 14.3% in Estonia; 18 11.4% in Germany; 25 9.4% in the UK; 37 8.1% in Northwest Spain; 22 5.7, 4.0 and 3.1% in Italy. 13, 24, 15 Values of R241 allele frequency (9.7 -11.9%) obtained in our sample population from the north-east of France are consistent with this north -south gradient. The G/R241 mutation results in a change from glycine to arginine in the third immunoglobulin domain of ICAM-1 protein, 10 which has been shown to be of importance in binding to the leukocyte integrin Mac-1. 38 The common allele is G241, and glycine is present at the analogous position in ICAM-1 from other species. 39 -41 Owing to the strong conservation of glycine at position 241, this mutation may possess a functional significance, probably by affecting Mac-1 binding. Otherwise, membrane-bound ICAM-1 acts as a signal transduction molecule in response to ligand binding with resulting activation of second messenger systems and gene transcription. 42 In this way, crosslinking ICAM-1 on primary human fibroblasts with anti-ICAM-1 antibody elicited a significant increase in ICAM-1 mRNA and protein expression. 43 Engagement of ICAM-1 triggers the stimulation of de novo ICAM-1 synthesis. Accordingly, we speculate that an R241 mutation decreases Mac-1 binding to ICAM-1 and thus reduces its positive feedback on ICAM-1 synthesis, which could explain the lower sICAM-1 level associated with the R241 allele.
We cannot exclude, however, the possibility that the effect of R241 mutation on sICAM-1 level may be due to linkage disequilibrium of this mutation with other genetic polymorphisms affecting sICAM-1 level. Only the K/E469 polymorphism of ICAM-1 gene was observed in linkage disequilibrium with the G/R241 mutation in patients affected by inflammatory disorders. 20 However, the association of K/E469 mutation with the protein level has never been studied and we cannot exclude that the effect of R241 allele on sICAM-1 level could be influenced by the K/E469 polymorphism. The association between the R241 allele and low sICAM-1 level observed in this study could seem to contradict the reported associations between the R241 allele and inflammatory disorders, 11 -15 and the increased sICAM-1 level at the related inflammation disorders. 4, 8, 26 The phenotypegenotype association described in our study was observed in a healthy population, and this relation cannot be excluded to remain significant in pathological states. The strong increase of sICAM-1 level due to inflammatory diseases could certainly hide the significant but weak decrease of sICAM-1 level associated with the R241 allele. Thus, additional studies are warranted to investigate the association between the R241 allele with sICAM-1 level in pathological state. Moreover, there is no general consensus about the relation between G/R241 polymorphism and inflammation. While some studies reported association between the R241 allele and inflammatory disorders, 11 -15 others did not. 16 -24 These conflicting results may be In addition to the G/R241 polymorphism, sICAM-1 level was influenced by various biological factors such as age, sex, smoking, insulin resistance, Il-6 level, and ALP and AST activities. Levels of sICAM-1 decreased during childhood and adolescence and varied very slightly between 38 and 55 years. The inverse relation between age and sICAM-1 level has been previously reported at childhood, 44 -47 but its physiological significance is currently unknown. At healthy adulthood, the stability of sICAM-1 level across age is well known. 31, 32, 34, 48 In our study, men had a slightly higher sICAM-1 level than women, probably due to the discrepancy in the older age group (48 -55 years). The variation of sICAM-1 level according to sex has not been established yet. However, sex difference could be due to hormonal effect: adhesion molecule expression decreased after estrogen treatment in in vitro studies 49, 50 and sICAM-1 level decreased in postmenopausal women under hormone therapy. 51 -54 Heavy smoking increased sICAM-1 level in the adults in our study in accordance with others; 31,33,55 -59 tobacco stimulates endothelial cells through proinflammatory pathways in in vitro studies. 60, 61 Our study shows that the insulin resistance index was positively related to sICAM-1 but only for children. An increased sICAM-1 level with increasing insulin resistance has been described already, but only for healthy adults. 62 It is possible that this association was only due to the higher HOMA index in children than in adults. 63 Il-6, a proinflammatory cytokine, was positively associated with sICAM-1 level without significant association with the other inflammatory markers (CRP and TNF-a). In this way, in vivo studies have shown that Il-6 induced ICAM-1 expression. 35, 36 The sICAM-1 level was positively related to AST and ALP activities. Since the subjects were free of hepatic diseases and bone disorders, and inflammatory markers were included in the statistic regression model, these associations did not seem to be due to pathological status. To our knowledge, there is no information that could explain the biological basis of such relations with AST and ALP activities in the physiological state.
To summarize, the R241 allele of ICAM-1 gene is associated with lower serum sICAM-1 level in healthy subjects. This association is unaffected by parameters that influence sICAM-1 level, particularly age, sex and tobacco intake. This result outlines the impact of ICAM-1 gene polymorphism on protein expression; further studies are needed, however, to confirm the functional significance of the G/R241 mutation.
